Table 3.
Prevalence | |||||||||
---|---|---|---|---|---|---|---|---|---|
Substance Use | k | n | I2 ** | 95% CIs | Prevalence in AN | n for AN-R | Prevalence in AN-R | n for AN-BP | Prevalence in AN-BP |
Alcohol | 5 | 677 | 70.56% | 0.22,0.36 | 29% | 172 | 31% | 156 | 43% |
Amphetamines | 3 | 326 | 0.01, 0.06 | 3% | N/A | N/A | N/A | N/A | |
Barbiturates | 2 | 160 | 0.00, 0.05 | 2% | N/A | N/A | N/A | N/A | |
Caffeine | 3 | 107 | 0.08, 0.73 | 37% | N/A | N/A | N/A | N/A | |
Cannabis | 5 | 720 | 95.18% | 0.03, 0.28 | 14% | 283 | 16% | 211 | 33% |
Cocaine | 3 | 326 | 0.00, 0.04 | 1% | 111 | 0% | 55 | 0% | |
Diazepam | 1* | 26 | 0.00, 0.20 | 4% | N/A | N/A | N/A | N/A | |
Hallucinogens | 2 | 161 | 0.00, 0.02 | 0% | N/A | N/A | N/A | N/A | |
Heroin | 1* | 166 | 0.00, 0.02 | 0% | N/A | N/A | N/A | N/A | |
Inhalants | 2 | 148 | 0.00, 0.04 | 1% | N/A | N/A | N/A | N/A | |
Opiates | 3 | 521 | 0.00, 0.24 | 5% | 111 | 1% | 55 | 2% | |
Phencyclidine | 1* | 26 | 0.00, 0.13 | 0% | N/A | N/A | N/A | N/A | |
Quaaludes | 1* | 26 | 0.00, 0.20 | 4% | N/A | N/A | N/A | N/A | |
Stimulants | 2 | 383 | 0.11, 0.18 | 14% | N/A | N/A | N/A | N/A | |
Tobacco | 9 | 1352 | 90.64% | 0.16, 0.34 | 25% | 255 | 26% | 788 | 32% |
Tranquilizers | 1* | 134 | 0.00, 0.06 | 2% | N/A | N/A | N/A | N/A | |
Other Substance Use | 1* | 328 | 0.10, 0.18 | 14% | N/A | N/A | N/A | N/A | |
Substance Use Total | 4 | 769 | 94.27% | 0.08, 0.34 | 20% | 111 | 5% | 55 | 18% |
*not derived from meta-analysis data, ** I2 only derived when pooled meta-analysis included 4 or more studies
AN anorexia nervosa; AN-BP anorexia nervosa binge-eating/purge type; AN-R anorexia nervosa restrictive type; CIs = confidence intervals; k amount of studies